Details for New Drug Application (NDA): 009000
✉ Email this page to a colleague
NDA 009000 describes CAFERGOT, which is a drug marketed by Novartis and Sandoz and is included in three NDAs. Additional details are available on the CAFERGOT profile page.
The generic ingredient in CAFERGOT is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
The generic ingredient in CAFERGOT is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
Summary for 009000
| Tradename: | CAFERGOT |
| Applicant: | Novartis |
| Ingredient: | caffeine; ergotamine tartrate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 100MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
